Mathias D. Buron

Hillerod, 3400, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Socioeconomic impact of initial high vs. moderate efficacy disease-modifying therapy in multiple sclerosis: Effects on labor market affiliation.

Socioeconomic impact of initial high vs. moderate efficacy disease-modifying therapy in multiple sclerosis: Effects on labor market affiliation.

Journal: Multiple sclerosis and related disorders

Published: February 04, 2025

Title Not Found

Title Not Found

Journal: Ugeskrift for laeger

Published: November 13, 2024

A wearable device perspective on the standard definitions of disability progression in multiple sclerosis.

A wearable device perspective on the standard definitions of disability progression in multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: December 12, 2023

Automatic Assessment of the 2-Minute Walk Distance for Remote Monitoring of People with Multiple Sclerosis.

Automatic Assessment of the 2-Minute Walk Distance for Remote Monitoring of People with Multiple Sclerosis.

Journal: Sensors (Basel, Switzerland)

Published: May 01, 2023

Autonomic response to walk tests is useful for assessing outcome measures in people with multiple sclerosis.

Autonomic response to walk tests is useful for assessing outcome measures in people with multiple sclerosis.

Journal: Frontiers in physiology

Published: January 16, 2023

Natalizumab treatment of multiple sclerosis - a Danish nationwide study with 13 years of follow-up.

Natalizumab treatment of multiple sclerosis - a Danish nationwide study with 13 years of follow-up.

Journal: Multiple sclerosis and related disorders

Published: January 11, 2023

Biopsychosocial Response to the COVID-19 Lockdown in People with Major Depressive Disorder and Multiple Sclerosis.

Biopsychosocial Response to the COVID-19 Lockdown in People with Major Depressive Disorder and Multiple Sclerosis.

Journal: Journal of clinical medicine

Published: October 05, 2022

Time to first treatment and risk of disability pension in relapsing-remitting multiple sclerosis.

Time to first treatment and risk of disability pension in relapsing-remitting multiple sclerosis.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: February 09, 2022

Aging With Multiple Sclerosis: Age-Related Factors and Socioeconomic Risks.

Aging With Multiple Sclerosis: Age-Related Factors and Socioeconomic Risks.

Journal: Frontiers in neurology

Published: November 19, 2021

Real-world outcomes for a complete nationwide cohort of more than 3200 teriflunomide-treated multiple sclerosis patients in The Danish Multiple Sclerosis Registry.

Real-world outcomes for a complete nationwide cohort of more than 3200 teriflunomide-treated multiple sclerosis patients in The Danish Multiple Sclerosis Registry.

Journal: PloS one

Published: December 01, 2020

Late-onset MS is associated with an increased rate of reaching disability milestones.

Late-onset MS is associated with an increased rate of reaching disability milestones.

Journal: Journal of neurology

Published: November 18, 2020

Effect of lateral therapy switches to oral moderate-efficacy drugs in multiple sclerosis: a nationwide cohort study.

Effect of lateral therapy switches to oral moderate-efficacy drugs in multiple sclerosis: a nationwide cohort study.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: August 12, 2020

Showing 1-12 of 18

Last Updated: 09/26/2026